This page was translated automatically from Turkish. Read the original

This page is an AI-assisted Turkish summary of the study presented at the 26th World Congress of Psychiatry. The study belongs to the presenting authors; please refer to the original source when citing it.

EV0344

Comorbid depression in chronic somatic diseases (diabetes mellitus, arterial hypertension, and chronic respiratory diseases)

COMORBID DEPRESSION IN CHRONIC SOMATIC DISEASES (DIABETES MELLITUS, ARTERIAL HYPERTENSION, AND CHRONIC RESPIRATORY CONDITIONS)

Mild, moderate, or severe depressive symptoms were identified in 81.8% of inpatients with chronic somatic diseases.

The aim was to assess the prevalence and severity of depressive symptoms in patients with chronic somatic diseases and to examine their clinical and sociodemographic associations. This was a cross-sectional, observational, descriptive-analytical study conducted over three months in the Department of Internal Medicine at Dnestrovsk City Hospital in the Republic of Moldova; of 168 eligible inpatients, 121 (72.0%) provided consent and were included in the analysis. The PHQ-9, BDI-21, and HAM-D-17 were used as assessment instruments, frequencies and percentages were calculated, and p<0.05 was considered statistically significant. Of the sample, 57.9% were men (n=70), 42.1% were women (n=51), 57.9% were over 60 years of age, 55.4% lived in urban areas, and 84.3% received treatment regularly; the diagnostic groups comprised arterial hypertension (n=36, 29.8%), coexisting arterial hypertension and diabetes mellitus (n=36, 29.8%), COPD (n=26, 21.5%), and diabetes mellitus (n=23, 19.0%). Mild, moderate, or severe depressive symptoms were present in 81.8% of participants. By disease group, mild symptoms predominated in diabetes mellitus, with rates of 39.1% for mild, 30.4% for moderate, and 8.7% for severe symptoms; in arterial hypertension, the distribution was relatively balanced, at 33.3%, 22.2%, and 13.9%, respectively. Moderate symptoms predominated among patients with coexisting hypertension and diabetes, with rates of 36.1%, 41.7%, and 13.9%, respectively, and among those with COPD, with corresponding rates of 42.3%, 46.2%, and 0.0%. The rate of severe depression was 18.2% among patients with a disease duration exceeding 10 years; among those receiving treatment irregularly, moderate depression was identified in 42.1% and severe depression in 15.8%. In conclusion, depressive symptoms are common in this group and are predominantly mild or moderate, with the burden increasing with longer disease duration, multimorbidity (particularly coexisting hypertension and diabetes), and irregular treatment adherence; the authors recommend incorporating routine screening and integrated medical and mental health care into chronic disease management.

All WCP 2026 summaries